These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 6767916)
1. [Usefulness of new drugs]. MMW Munch Med Wochenschr; 1980 Jan; 122(1):28-9. PubMed ID: 6767916 [No Abstract] [Full Text] [Related]
2. [The practicability of vaccinations]. Janetschek R Fortschr Med; 1977 Jan; 95(2):84-6. PubMed ID: 401761 [TBL] [Abstract][Full Text] [Related]
3. [Vaccination in children. Review for the general practice]. Sitzmann FC Fortschr Med; 1981 Sep; 99(35):1375-8. PubMed ID: 7024068 [No Abstract] [Full Text] [Related]
4. Global eradication of poliomyelitis: benefit-cost analysis. Bart KJ; Foulds J; Patriarca P Bull World Health Organ; 1996; 74(1):35-45. PubMed ID: 8653814 [TBL] [Abstract][Full Text] [Related]
6. [Nurse's role in the vaccination campaign against infantile paralysis and measles]. Sobral S Rev Bras Enferm; 1978; 31(4):449-65. PubMed ID: 261415 [No Abstract] [Full Text] [Related]
7. Immunization against poliomyelitis: still problems to solve in both developed and developing countries. Hovi T Ann Clin Res; 1986; 18(3):119-20. PubMed ID: 3740787 [No Abstract] [Full Text] [Related]
8. Cost and benefits of immunization in India. John TJ Indian Pediatr; 1981 Aug; 18(8):513-6. PubMed ID: 6796512 [No Abstract] [Full Text] [Related]
9. The cost-effectiveness of alternative polio immunization policies in South Africa. Griffiths UK; Botham L; Schoub BD Vaccine; 2006 Jul; 24(29-30):5670-8. PubMed ID: 16766096 [TBL] [Abstract][Full Text] [Related]
11. Risks of paralytic disease due to wild or vaccine-derived poliovirus after eradication. Tebbens RJ; Pallansch MA; Kew OM; Cáceres VM; Jafari H; Cochi SL; Sutter RW; Aylward RB; Thompson KM Risk Anal; 2006 Dec; 26(6):1471-505. PubMed ID: 17184393 [TBL] [Abstract][Full Text] [Related]
12. Poliomyelitis vaccination for the international traveler. Mann JM; Bernier RH; Hinman AR Am Fam Physician; 1982 Dec; 26(6):135-9. PubMed ID: 7148637 [TBL] [Abstract][Full Text] [Related]
13. Benefits, risks and costs of viral vaccines. Koplan JP; Axnick NW Prog Med Virol; 1982; 28():180-91. PubMed ID: 6806868 [No Abstract] [Full Text] [Related]
14. [Poliomyelitis: results of liver virus vaccination]. Sabin AB Bol Oficina Sanit Panam; 1968 Jul; 65(1):52-61. PubMed ID: 4233039 [No Abstract] [Full Text] [Related]
15. [Worldwide eradication of poliomyelitis]. Rasch G; Schreier E; Kiehl W; Kurth R Wien Klin Wochenschr; 2001 Oct; 113(20-21):839-45. PubMed ID: 11732120 [TBL] [Abstract][Full Text] [Related]
16. Opponents stymie fight against polio in Nigeria. Wakabi W CMAJ; 2008 Oct; 179(9):891. PubMed ID: 18936452 [No Abstract] [Full Text] [Related]
17. Anomalous observations on IPV and OPV vaccination. John TJ Dev Biol (Basel); 2001; 105():197-208. PubMed ID: 11763328 [TBL] [Abstract][Full Text] [Related]
18. [Vaccination strategies for the global eradication of poliomyelitis]. Bompart F Bull Soc Pathol Exot; 2004 Nov; 97(4):288-92. PubMed ID: 17304754 [TBL] [Abstract][Full Text] [Related]
19. A global overview and hope for the eradication of poliomyelitis by the year 2000. Ward N; Milstien J; Hull H; Hull B Trop Geogr Med; 1993; 45(5):198-202. PubMed ID: 8279055 [No Abstract] [Full Text] [Related]
20. Aaby P, Rodrigues A, Biai S, et al. Oral polio vaccination and low case fatality at the paediatric ward in Bissau, Guinea-Bissau. Vaccine 2004;22:3014-7. Hull HF Vaccine; 2005 Feb; 23(14):1637-8. PubMed ID: 15705466 [No Abstract] [Full Text] [Related] [Next] [New Search]